Sinovac Biotech SVA Estimates

NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT
Analyst Estimates

Sinovac Biotech Ltd Annual Revenue Estimates

Periods 3
Next Period 2017
Consensus 126.88 M

Analysts expect Sinovac Biotech Ltd to report revenue of 126.88 M for 2017, against a range of 118.59 M to 135.16 M. The most recent reported year, 2023, came in at 448.27 M.

Metric 201720232024
Reported (Actual) -448.27 M-
High Estimate 135.16 M0.000.00
Low Estimate 118.59 M0.000.00
Consensus Estimate 126.88 M0.000.00
Analyst Estimates

Sinovac Biotech Ltd Annual Earnings Per Share (EPS) Estimates

Periods 3
Next Period 2017
Consensus 0.09

Analysts expect Sinovac Biotech Ltd to report earnings per share of 0.09 for 2017, against a range of 0.08 to 0.10. The most recent reported year, 2023, came in at -1.06, a 863.6% miss against the -0.11 consensus.

Metric 201720232024
Reported (Actual) --1.06-
High Estimate 0.10-0.10-0.09
Low Estimate 0.08-0.12-0.09
Consensus Estimate 0.09-0.11-0.09

Sinovac Biotech Ltd Estimates API

Pull Wall Street consensus for Sinovac Biotech Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=SVA&mode=revenue&api_key=YOUR_API_KEY